Extract	B:C0032081
of	I:C0032081
Caulis	I:C0032081
Spatholobi	I:C0032081
,	O
a	O
novel	O
blocker	O
targeting	O
tumor	O
cell	I:C0032176
‑induced	I:C0032176
platelet	I:C0032176
aggregation	I:C0032176
,	O
inhibits	O
breast	O
cancer	I:C0006142
metastasis	O
.	O

Extract	O
of	I:C0032081
Caulis	I:C0032081
Spatholobi	I:C0032081
,	O
a	O
novel	O
blocker	B:C1254351
targeting	O
tumor	O
cell	I:C0032176
‑induced	I:C0032176
platelet	I:C0032176
aggregation	I:C0032176
,	O
inhibits	O
breast	O
cancer	I:C0006142
metastasis	O
.	O

Extract	O
of	I:C0032081
Caulis	I:C0032081
Spatholobi	I:C0032081
,	O
a	O
novel	O
blocker	O
targeting	O
tumor	B:C0032176
cell	I:C0032176
‑induced	I:C0032176
platelet	I:C0032176
aggregation	I:C0032176
,	O
inhibits	O
breast	O
cancer	I:C0006142
metastasis	O
.	O

Extract	O
of	I:C0032081
Caulis	I:C0032081
Spatholobi	I:C0032081
,	O
a	O
novel	O
blocker	O
targeting	O
tumor	O
cell	I:C0032176
‑induced	I:C0032176
platelet	I:C0032176
aggregation	I:C0032176
,	O
inhibits	O
breast	B:C0006142
cancer	I:C0006142
metastasis	O
.	O

Extract	O
of	I:C0032081
Caulis	I:C0032081
Spatholobi	I:C0032081
,	O
a	O
novel	O
blocker	O
targeting	O
tumor	O
cell	I:C0032176
‑induced	I:C0032176
platelet	I:C0032176
aggregation	I:C0032176
,	O
inhibits	O
breast	O
cancer	I:C0006142
metastasis	B:C0027627
.	O

Metastasis	B:C0027627
of	O
breast	O
cancer	I:C0006142
is	O
the	O
vital	O
step	O
for	O
malignant	O
progression	I:C0948048
.	O

Metastasis	O
of	O
breast	B:C0006142
cancer	I:C0006142
is	O
the	O
vital	O
step	O
for	O
malignant	O
progression	I:C0948048
.	O

Metastasis	O
of	O
breast	O
cancer	I:C0006142
is	O
the	O
vital	O
step	O
for	O
malignant	B:C0948048
progression	I:C0948048
.	O

During	O
such	O
a	O
process	O
,	O
hematogenous	B:C0027627
metastasis	I:C0027627
is	O
an	O
indispensable	O
approach	O
for	O
the	O
dissemination	O
of	O
cancer	O
cells	I:C0334227
.	O

During	O
such	O
a	O
process	O
,	O
hematogenous	O
metastasis	I:C0027627
is	O
an	O
indispensable	O
approach	O
for	O
the	O
dissemination	O
of	O
cancer	B:C0334227
cells	I:C0334227
.	O

A	O
platelet	B:C0005821
,	O
contributes	O
to	O
hypercoagulable	O
state	I:C0398623
,	O
and	O
is	O
also	O
identified	O
the	O
crucial	O
factor	O
in	O
the	O
coagulation	O
system	O
for	O
supporting	O
metastasis	O
.	O

A	O
platelet	O
,	O
contributes	O
to	O
hypercoagulable	B:C0398623
state	I:C0398623
,	O
and	O
is	O
also	O
identified	O
the	O
crucial	O
factor	O
in	O
the	O
coagulation	O
system	O
for	O
supporting	O
metastasis	O
.	O

A	O
platelet	O
,	O
contributes	O
to	O
hypercoagulable	O
state	I:C0398623
,	O
and	O
is	O
also	O
identified	O
the	O
crucial	O
factor	O
in	O
the	O
coagulation	B:C0005778
system	O
for	O
supporting	O
metastasis	O
.	O

A	O
platelet	O
,	O
contributes	O
to	O
hypercoagulable	O
state	I:C0398623
,	O
and	O
is	O
also	O
identified	O
the	O
crucial	O
factor	O
in	O
the	O
coagulation	O
system	O
for	O
supporting	O
metastasis	B:C0027627
.	O

Therefore	O
,	O
the	O
relationship	O
of	O
a	O
platelet	B:C0005821
and	O
a	O
tumor	O
cell	I:C0597032
plays	O
a	O
critical	O
role	O
in	O
tumor	O
cell	I:C0597032
metastasis	O
.	O

Therefore	O
,	O
the	O
relationship	O
of	O
a	O
platelet	O
and	O
a	O
tumor	B:C0597032
cell	I:C0597032
plays	O
a	O
critical	O
role	O
in	O
tumor	O
cell	I:C0597032
metastasis	O
.	O

Therefore	O
,	O
the	O
relationship	O
of	O
a	O
platelet	O
and	O
a	O
tumor	O
cell	I:C0597032
plays	O
a	O
critical	O
role	O
in	O
tumor	B:C0597032
cell	I:C0597032
metastasis	O
.	O

Therefore	O
,	O
the	O
relationship	O
of	O
a	O
platelet	O
and	O
a	O
tumor	O
cell	I:C0597032
plays	O
a	O
critical	O
role	O
in	O
tumor	O
cell	I:C0597032
metastasis	B:C0027627
.	O

Consequently	O
,	O
inhibiting	O
tumor	B:C0032176
cell	I:C0032176
‑induced	I:C0032176
platelet	I:C0032176
aggregation	I:C0032176
(	O
tumor	O
cell	I:C0032176
‑induced	I:C0032176
platelet	I:C0032176
aggregation	I:C0032176
)	O
is	O
recongnized	O
as	O
a	O
crucial	O
target	O
on	O
suppression	O
of	O
tumor	O
metastasis	I:C0027627
such	O
as	O
aspirin	O
(	O
as	O
aspirin	I:C0004057
)	O
.	O

Consequently	O
,	O
inhibiting	O
tumor	O
cell	I:C0032176
‑induced	I:C0032176
platelet	I:C0032176
aggregation	I:C0032176
(	O
tumor	B:C0032176
cell	I:C0032176
‑induced	I:C0032176
platelet	I:C0032176
aggregation	I:C0032176
)	O
is	O
recongnized	O
as	O
a	O
crucial	O
target	O
on	O
suppression	O
of	O
tumor	O
metastasis	I:C0027627
such	O
as	O
aspirin	O
(	O
as	O
aspirin	I:C0004057
)	O
.	O

Consequently	O
,	O
inhibiting	O
tumor	O
cell	I:C0032176
‑induced	I:C0032176
platelet	I:C0032176
aggregation	I:C0032176
(	O
tumor	O
cell	I:C0032176
‑induced	I:C0032176
platelet	I:C0032176
aggregation	I:C0032176
)	O
is	O
recongnized	O
as	O
a	O
crucial	O
target	O
on	O
suppression	B:C1519692
of	O
tumor	O
metastasis	I:C0027627
such	O
as	O
aspirin	O
(	O
as	O
aspirin	I:C0004057
)	O
.	O

Consequently	O
,	O
inhibiting	O
tumor	O
cell	I:C0032176
‑induced	I:C0032176
platelet	I:C0032176
aggregation	I:C0032176
(	O
tumor	O
cell	I:C0032176
‑induced	I:C0032176
platelet	I:C0032176
aggregation	I:C0032176
)	O
is	O
recongnized	O
as	O
a	O
crucial	O
target	O
on	O
suppression	O
of	O
tumor	B:C0027627
metastasis	I:C0027627
such	O
as	O
aspirin	O
(	O
as	O
aspirin	I:C0004057
)	O
.	O

Consequently	O
,	O
inhibiting	O
tumor	O
cell	I:C0032176
‑induced	I:C0032176
platelet	I:C0032176
aggregation	I:C0032176
(	O
tumor	O
cell	I:C0032176
‑induced	I:C0032176
platelet	I:C0032176
aggregation	I:C0032176
)	O
is	O
recongnized	O
as	O
a	O
crucial	O
target	O
on	O
suppression	O
of	O
tumor	O
metastasis	I:C0027627
such	O
as	O
aspirin	B:C0004057
(	O
as	O
aspirin	I:C0004057
)	O
.	O

Consequently	O
,	O
inhibiting	O
tumor	O
cell	I:C0032176
‑induced	I:C0032176
platelet	I:C0032176
aggregation	I:C0032176
(	O
tumor	O
cell	I:C0032176
‑induced	I:C0032176
platelet	I:C0032176
aggregation	I:C0032176
)	O
is	O
recongnized	O
as	O
a	O
crucial	O
target	O
on	O
suppression	O
of	O
tumor	O
metastasis	I:C0027627
such	O
as	O
aspirin	O
(	O
as	B:C0004057
aspirin	I:C0004057
)	O
.	O

Under	O
such	O
circumstance	O
,	O
here	O
we	O
report	O
that	O
,	O
through	O
dissociating	O
the	O
tumor‑platelet	B:C0243092
(	I:C0243092
T‑P	I:C0243092
)	I:C0243092
complex	I:C0243092
,	I:C0243092
80	O
%	O
ethanol	O
extracts	O
of	I:C0032081
Caulis	I:C0032081
Spatholobi	I:C0032081
(	O
SET	O
)	O
successfully	O
alleviated	O
the	O
hypercoagulation	O
state	I:C0398623
,	O
thereby	O
reducing	O
tumor	O
metastasis	I:C0027627
and	O
improving	O
the	O
prospects	O
of	O
survival	O
in	O
breast	O
cancer	O
cell	I:C0334227
model	O
.	O

Under	O
such	O
circumstance	O
,	O
here	O
we	O
report	O
that	O
,	O
through	O
dissociating	O
the	O
tumor‑platelet	O
(	I:C0243092
T‑P	I:C0243092
)	I:C0243092
complex	I:C0243092
,	I:C0243092
80	O
%	O
ethanol	B:C0001962
extracts	O
of	I:C0032081
Caulis	I:C0032081
Spatholobi	I:C0032081
(	O
SET	O
)	O
successfully	O
alleviated	O
the	O
hypercoagulation	O
state	I:C0398623
,	O
thereby	O
reducing	O
tumor	O
metastasis	I:C0027627
and	O
improving	O
the	O
prospects	O
of	O
survival	O
in	O
breast	O
cancer	O
cell	I:C0334227
model	O
.	O

Under	O
such	O
circumstance	O
,	O
here	O
we	O
report	O
that	O
,	O
through	O
dissociating	O
the	O
tumor‑platelet	O
(	I:C0243092
T‑P	I:C0243092
)	I:C0243092
complex	I:C0243092
,	I:C0243092
80	O
%	O
ethanol	O
extracts	B:C0032081
of	I:C0032081
Caulis	I:C0032081
Spatholobi	I:C0032081
(	O
SET	O
)	O
successfully	O
alleviated	O
the	O
hypercoagulation	O
state	I:C0398623
,	O
thereby	O
reducing	O
tumor	O
metastasis	I:C0027627
and	O
improving	O
the	O
prospects	O
of	O
survival	O
in	O
breast	O
cancer	O
cell	I:C0334227
model	O
.	O

Under	O
such	O
circumstance	O
,	O
here	O
we	O
report	O
that	O
,	O
through	O
dissociating	O
the	O
tumor‑platelet	O
(	I:C0243092
T‑P	I:C0243092
)	I:C0243092
complex	I:C0243092
,	I:C0243092
80	O
%	O
ethanol	O
extracts	O
of	I:C0032081
Caulis	I:C0032081
Spatholobi	I:C0032081
(	O
SET	B:C0032081
)	O
successfully	O
alleviated	O
the	O
hypercoagulation	O
state	I:C0398623
,	O
thereby	O
reducing	O
tumor	O
metastasis	I:C0027627
and	O
improving	O
the	O
prospects	O
of	O
survival	O
in	O
breast	O
cancer	O
cell	I:C0334227
model	O
.	O

Under	O
such	O
circumstance	O
,	O
here	O
we	O
report	O
that	O
,	O
through	O
dissociating	O
the	O
tumor‑platelet	O
(	I:C0243092
T‑P	I:C0243092
)	I:C0243092
complex	I:C0243092
,	I:C0243092
80	O
%	O
ethanol	O
extracts	O
of	I:C0032081
Caulis	I:C0032081
Spatholobi	I:C0032081
(	O
SET	O
)	O
successfully	O
alleviated	O
the	O
hypercoagulation	B:C0398623
state	I:C0398623
,	O
thereby	O
reducing	O
tumor	O
metastasis	I:C0027627
and	O
improving	O
the	O
prospects	O
of	O
survival	O
in	O
breast	O
cancer	O
cell	I:C0334227
model	O
.	O

Under	O
such	O
circumstance	O
,	O
here	O
we	O
report	O
that	O
,	O
through	O
dissociating	O
the	O
tumor‑platelet	O
(	I:C0243092
T‑P	I:C0243092
)	I:C0243092
complex	I:C0243092
,	I:C0243092
80	O
%	O
ethanol	O
extracts	O
of	I:C0032081
Caulis	I:C0032081
Spatholobi	I:C0032081
(	O
SET	O
)	O
successfully	O
alleviated	O
the	O
hypercoagulation	O
state	I:C0398623
,	O
thereby	O
reducing	O
tumor	B:C0027627
metastasis	I:C0027627
and	O
improving	O
the	O
prospects	O
of	O
survival	O
in	O
breast	O
cancer	O
cell	I:C0334227
model	O
.	O

Under	O
such	O
circumstance	O
,	O
here	O
we	O
report	O
that	O
,	O
through	O
dissociating	O
the	O
tumor‑platelet	O
(	I:C0243092
T‑P	I:C0243092
)	I:C0243092
complex	I:C0243092
,	I:C0243092
80	O
%	O
ethanol	O
extracts	O
of	I:C0032081
Caulis	I:C0032081
Spatholobi	I:C0032081
(	O
SET	O
)	O
successfully	O
alleviated	O
the	O
hypercoagulation	O
state	I:C0398623
,	O
thereby	O
reducing	O
tumor	O
metastasis	I:C0027627
and	O
improving	O
the	O
prospects	O
of	O
survival	O
in	O
breast	B:C0006141
cancer	O
cell	I:C0334227
model	O
.	O

Under	O
such	O
circumstance	O
,	O
here	O
we	O
report	O
that	O
,	O
through	O
dissociating	O
the	O
tumor‑platelet	O
(	I:C0243092
T‑P	I:C0243092
)	I:C0243092
complex	I:C0243092
,	I:C0243092
80	O
%	O
ethanol	O
extracts	O
of	I:C0032081
Caulis	I:C0032081
Spatholobi	I:C0032081
(	O
SET	O
)	O
successfully	O
alleviated	O
the	O
hypercoagulation	O
state	I:C0398623
,	O
thereby	O
reducing	O
tumor	O
metastasis	I:C0027627
and	O
improving	O
the	O
prospects	O
of	O
survival	O
in	O
breast	O
cancer	B:C0334227
cell	I:C0334227
model	O
.	O

Through	O
MTT	B:C0201596
and	O
anti‑aggregation	O
assay	I:C0005507
stimulated	I:C0005507
by	I:C0005507
ADP	I:C0005507
,	O
we	O
detected	O
the	O
optimum	O
treatment	O
time	O
and	O
the	O
optimum	O
dose	O
of	O
SET	O
.	O

Through	O
MTT	O
and	O
anti‑aggregation	B:C0005507
assay	I:C0005507
stimulated	I:C0005507
by	I:C0005507
ADP	I:C0005507
,	O
we	O
detected	O
the	O
optimum	O
treatment	O
time	O
and	O
the	O
optimum	O
dose	O
of	O
SET	O
.	O

Through	O
MTT	O
and	O
anti‑aggregation	O
assay	I:C0005507
stimulated	I:C0005507
by	I:C0005507
ADP	I:C0005507
,	O
we	O
detected	O
the	O
optimum	O
treatment	O
time	O
and	O
the	O
optimum	O
dose	O
of	O
SET	B:C0032081
.	O

By	O
using	O
confocal	B:C0242842
microscopy	I:C0242842
,	O
we	O
observed	O
that	O
SET	O
can	O
strongly	O
block	O
the	O
formation	O
of	O
T‑P	O
complex	I:C0243092
i	O
n	O
vitro	O
.	O

By	O
using	O
confocal	O
microscopy	I:C0242842
,	O
we	O
observed	O
that	O
SET	B:C0032081
can	O
strongly	O
block	O
the	O
formation	O
of	O
T‑P	O
complex	I:C0243092
i	O
n	O
vitro	O
.	O

By	O
using	O
confocal	O
microscopy	I:C0242842
,	O
we	O
observed	O
that	O
SET	O
can	O
strongly	O
block	O
the	O
formation	O
of	O
T‑P	B:C0243092
complex	I:C0243092
i	O
n	O
vitro	O
.	O

The	O
result	O
was	O
further	O
quantified	O
and	O
confirmed	O
by	O
the	O
FACS	B:C0079366
analysis	I:C0079366
.	O

The	O
fluorescent	O
value	O
of	O
T‑P	B:C0243092
complex	I:C0243092
was	O
obviously	O
decreased	O
in	O
the	O
drug‑treated	O
groups	O
.	O

In	B:C1515655
vivo	I:C1515655
,	O
4T1	O
cells	I:C0597032
were	O
injected	O
through	O
the	O
mouse	O
tail	O
vein	I:C2985205
for	O
dynamic	O
visualization	I:C0430022
by	O
small	O
animal	O
imaging	O
system	O
.	O

In	O
vivo	I:C1515655
,	O
4T1	B:C0597032
cells	I:C0597032
were	O
injected	O
through	O
the	O
mouse	O
tail	O
vein	I:C2985205
for	O
dynamic	O
visualization	I:C0430022
by	O
small	O
animal	O
imaging	O
system	O
.	O

In	O
vivo	I:C1515655
,	O
4T1	O
cells	I:C0597032
were	O
injected	B:C1533685
through	O
the	O
mouse	O
tail	O
vein	I:C2985205
for	O
dynamic	O
visualization	I:C0430022
by	O
small	O
animal	O
imaging	O
system	O
.	O

In	O
vivo	I:C1515655
,	O
4T1	O
cells	I:C0597032
were	O
injected	O
through	O
the	O
mouse	B:C0025929
tail	O
vein	I:C2985205
for	O
dynamic	O
visualization	I:C0430022
by	O
small	O
animal	O
imaging	O
system	O
.	O

In	O
vivo	I:C1515655
,	O
4T1	O
cells	I:C0597032
were	O
injected	O
through	O
the	O
mouse	O
tail	B:C2985205
vein	I:C2985205
for	O
dynamic	O
visualization	I:C0430022
by	O
small	O
animal	O
imaging	O
system	O
.	O

In	O
vivo	I:C1515655
,	O
4T1	O
cells	I:C0597032
were	O
injected	O
through	O
the	O
mouse	O
tail	O
vein	I:C2985205
for	O
dynamic	B:C0430022
visualization	I:C0430022
by	O
small	O
animal	O
imaging	O
system	O
.	O

The	O
metastatic	O
intensity	O
was	O
quantified	O
and	O
the	O
survival	O
curve	O
was	O
analyzed	B:C0936012
.	O

Additionally	O
,	O
general	O
observation	O
and	O
hematoxylin	B:C0523207
and	I:C0523207
eosin	I:C0523207
(	I:C0523207
H&E	I:C0523207
)	I:C0523207
staining	I:C0523207
of	O
lung	O
tissue	O
was	O
performed	O
.	O

Additionally	O
,	O
general	O
observation	O
and	O
hematoxylin	O
and	I:C0523207
eosin	I:C0523207
(	I:C0523207
H&E	I:C0523207
)	I:C0523207
staining	I:C0523207
of	O
lung	B:C0024109
tissue	O
was	O
performed	O
.	O

Additionally	O
,	O
general	O
observation	O
and	O
hematoxylin	O
and	I:C0523207
eosin	I:C0523207
(	I:C0523207
H&E	I:C0523207
)	I:C0523207
staining	I:C0523207
of	O
lung	O
tissue	B:C0040300
was	O
performed	O
.	O

SET	B:C0032081
exerted	O
an	O
obvious	O
effect	O
on	O
the	O
inhibition	O
of	O
metastasis	O
and	O
increasing	O
the	O
survival	O
rate	O
of	O
mice	O
.	O

SET	O
exerted	O
an	O
obvious	O
effect	O
on	O
the	O
inhibition	O
of	O
metastasis	B:C0027627
and	O
increasing	O
the	O
survival	O
rate	O
of	O
mice	O
.	O

SET	O
exerted	O
an	O
obvious	O
effect	O
on	O
the	O
inhibition	O
of	O
metastasis	O
and	O
increasing	O
the	O
survival	O
rate	O
of	O
mice	B:C0025929
.	O

For	O
the	O
molecular	B:C1148560
mechanism	I:C1148560
study	O
of	O
anti‑TCIPA	O
,	O
zymography	O
and	O
R	O
T‑PCR	O
assay	I:C0599161
preliminarily	O
revealed	O
the	O
molecular	O
mechanism	I:C1148560
of	O
SET	O
in	O
the	O
regulation	O
of	O
P	O
‑T	O
interaction	I:C0007582
.	O

For	O
the	O
molecular	O
mechanism	I:C1148560
study	B:C2603343
of	O
anti‑TCIPA	O
,	O
zymography	O
and	O
R	O
T‑PCR	O
assay	I:C0599161
preliminarily	O
revealed	O
the	O
molecular	O
mechanism	I:C1148560
of	O
SET	O
in	O
the	O
regulation	O
of	O
P	O
‑T	O
interaction	I:C0007582
.	O

For	O
the	O
molecular	O
mechanism	I:C1148560
study	O
of	O
anti‑TCIPA	B:C0005507
,	O
zymography	O
and	O
R	O
T‑PCR	O
assay	I:C0599161
preliminarily	O
revealed	O
the	O
molecular	O
mechanism	I:C1148560
of	O
SET	O
in	O
the	O
regulation	O
of	O
P	O
‑T	O
interaction	I:C0007582
.	O

For	O
the	O
molecular	O
mechanism	I:C1148560
study	O
of	O
anti‑TCIPA	O
,	O
zymography	B:C1517469
and	O
R	O
T‑PCR	O
assay	I:C0599161
preliminarily	O
revealed	O
the	O
molecular	O
mechanism	I:C1148560
of	O
SET	O
in	O
the	O
regulation	O
of	O
P	O
‑T	O
interaction	I:C0007582
.	O

For	O
the	O
molecular	O
mechanism	I:C1148560
study	O
of	O
anti‑TCIPA	O
,	O
zymography	O
and	O
R	O
T‑PCR	B:C0599161
assay	I:C0599161
preliminarily	O
revealed	O
the	O
molecular	O
mechanism	I:C1148560
of	O
SET	O
in	O
the	O
regulation	O
of	O
P	O
‑T	O
interaction	I:C0007582
.	O

For	O
the	O
molecular	O
mechanism	I:C1148560
study	O
of	O
anti‑TCIPA	O
,	O
zymography	O
and	O
R	O
T‑PCR	O
assay	I:C0599161
preliminarily	O
revealed	O
the	O
molecular	B:C1148560
mechanism	I:C1148560
of	O
SET	O
in	O
the	O
regulation	O
of	O
P	O
‑T	O
interaction	I:C0007582
.	O

For	O
the	O
molecular	O
mechanism	I:C1148560
study	O
of	O
anti‑TCIPA	O
,	O
zymography	O
and	O
R	O
T‑PCR	O
assay	I:C0599161
preliminarily	O
revealed	O
the	O
molecular	O
mechanism	I:C1148560
of	O
SET	B:C0032081
in	O
the	O
regulation	O
of	O
P	O
‑T	O
interaction	I:C0007582
.	O

For	O
the	O
molecular	O
mechanism	I:C1148560
study	O
of	O
anti‑TCIPA	O
,	O
zymography	O
and	O
R	O
T‑PCR	O
assay	I:C0599161
preliminarily	O
revealed	O
the	O
molecular	O
mechanism	I:C1148560
of	O
SET	O
in	O
the	O
regulation	O
of	O
P	O
‑T	B:C0007582
interaction	I:C0007582
.	O

Collectively	O
,	O
through	O
drug	O
efficacy	O
identification	O
and	O
pharmacological	O
revealing	O
,	O
we	O
have	O
obtained	O
a	O
promising	O
candidate	O
for	O
the	O
interference	O
of	O
breast	B:C0006141
metastasis	O
by	O
suppressing	O
tumor	O
cell	I:C0032176
‑induced	I:C0032176
platelet	I:C0032176
aggregation	I:C0032176
,	O
which	O
will	O
be	O
beneficial	O
for	O
clinical	O
cancer	O
treatment	I:C0920425
.	O

Collectively	O
,	O
through	O
drug	O
efficacy	O
identification	O
and	O
pharmacological	O
revealing	O
,	O
we	O
have	O
obtained	O
a	O
promising	O
candidate	O
for	O
the	O
interference	O
of	O
breast	O
metastasis	B:C0027627
by	O
suppressing	O
tumor	O
cell	I:C0032176
‑induced	I:C0032176
platelet	I:C0032176
aggregation	I:C0032176
,	O
which	O
will	O
be	O
beneficial	O
for	O
clinical	O
cancer	O
treatment	I:C0920425
.	O

Collectively	O
,	O
through	O
drug	O
efficacy	O
identification	O
and	O
pharmacological	O
revealing	O
,	O
we	O
have	O
obtained	O
a	O
promising	O
candidate	O
for	O
the	O
interference	O
of	O
breast	O
metastasis	O
by	O
suppressing	O
tumor	B:C0032176
cell	I:C0032176
‑induced	I:C0032176
platelet	I:C0032176
aggregation	I:C0032176
,	O
which	O
will	O
be	O
beneficial	O
for	O
clinical	O
cancer	O
treatment	I:C0920425
.	O

Collectively	O
,	O
through	O
drug	O
efficacy	O
identification	O
and	O
pharmacological	O
revealing	O
,	O
we	O
have	O
obtained	O
a	O
promising	O
candidate	O
for	O
the	O
interference	O
of	O
breast	O
metastasis	O
by	O
suppressing	O
tumor	O
cell	I:C0032176
‑induced	I:C0032176
platelet	I:C0032176
aggregation	I:C0032176
,	O
which	O
will	O
be	O
beneficial	O
for	O
clinical	O
cancer	B:C0920425
treatment	I:C0920425
.	O

